INGRID ORTIZ: Open Payments
NPI 1225669138 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,228 in 88 payments from 21 companies in 2025. Trend: 2023 $3,267 · 2024 $2,705 · 2025 $2,228
Food & beverage: $2,228
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 15 | $459 |
| Endo USA, Inc. | 9 | $296 |
| ABBVIE INC. | 12 | $269 |
| PFIZER INC. | 8 | $170 |
| Astellas Pharma US Inc | 7 | $157 |
| E.R. Squibb & Sons, L.L.C. | 1 | $119 |
| COLOPLAST CORP | 6 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $95 |
| Janssen Biotech, Inc. | 3 | $76 |
| Merck Sharp & Dohme LLC | 3 | $71 |
Products named: GEMTESA, Xtandi, BOTOX, XIAFLEX, COBENFY, ORGOVYX, AVEED, Nubeqa.
Industry payments across VA — which companies pay providers there.
